Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;29(3):247-52.
doi: 10.3233/NRE-2011-0700.

Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease

M S Bryant  1 , D H Rintala, J G Hou, E C Lai, E J Protas
Affiliations

Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease

M S Bryant et al. NeuroRehabilitation. 2011.

Abstract

Introduction: Backward walking is difficult for persons with Parkinson's disease (PD). It is unknown how levodopa influences backward gait patterns, especially when compared to forward gait patterns.

Purpose: Investigate the effects of levodopa on forward and backward gait patterns in individuals with PD.

Design: A repeated measures design was used.

Methods: The sample consisted of 21 individuals with PD (15 males, 6 females). Their mean age was 70.24 ± 8.69 yr. The average time since diagnosis was 11.81 ± 5.49 years. The median of the Hoehn and Yahr stage while 'ON' medication was 2.57. Gait patterns during forward and backward walking at a self-selected comfortable speed were recorded before and after taking levodopa on the same day.

Results: Levodopa significantly increased gait speed and stride length and decreased the percent of the gait cycle (%GC) spent in double support. Gait speed and stride length were greater and the %GC spent in double support was less during forward walking compared with backward walking. Cadence was not changed by levodopa or walking direction.

Conclusions: Levodopa improved gait characteristics during backward walking in a manner similar to that during forward walking in persons with PD.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest concerning the research related to manuscripts by all authors.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Blin O, Ferrandez AM, Pailhous J, Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. Journal of the Neurological Science. 1991;103(1):51–54. - PubMed
    1. Bowes SG, Clark PK, Leeman AL, O'Neill CJ, Weller C, Nicholson PW, Deshmukh AA, Dobbs SM, Dobbs RJ. Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy. British Journal of Clinical Pharmacology. 1990;30(1):13–24. - PMC - PubMed
    1. CIR Systems, Inc. GAITRite Operating Manual, Version 3.9. Havertown; 2007.
    1. Fahn S, Elton RL . Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Vol. 2. Florham Park: Macmillan Health Care Information; 1987.
    1. Hackney ME, Earhart GM. Backward walking in Parkinson's disease. Movement Disorders. 2009;30, 24(2):218–223. - PMC - PubMed

Publication types